Aptar Pharma is featured in the April 2019 edition of ONdrugDelivery magazine, which focuses this month on Pulmonary & Nasal Drug Delivery.
In this in-depth interview, Aptar Pharma’s Guillaume Brouet, Vice-President Analytical, Regulatory and Scientific Affairs, discusses Aptar Pharma’s comprehensive range of services available to customers around device development, the importance of offering services with a patient-centric approach, and Aptar’s proven expertise in regulatory and combination product approvals.
Read the full article: Aptar Pharma discusses services for patient-centric drug development..
